Trials / Completed
CompletedNCT03659201
Efficacy and Safety of Neosil on Chronic Effluvium
Randomized Clinical Trial, Placebo Controlled and Active Comparator, to Evaluate Efficacy and Safety of Neosil in Chronic Effluvium
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 232 (actual)
- Sponsor
- EMS · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neosil complete | Oral, during 24 weeks. |
| DRUG | Pantogar | Oral, placebo for 12 weeks and pantogar for 12 weeks. |
| DRUG | Neosil | Oral, during only 12 weeks. |
Timeline
- Start date
- 2018-09-03
- Primary completion
- 2019-06-04
- Completion
- 2020-03-30
- First posted
- 2018-09-06
- Last updated
- 2020-04-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03659201. Inclusion in this directory is not an endorsement.